Fatty liver disease (MASLD/MASH) trials in Malaysia
3 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Ampang, Kota Bharu, Kuala Lumpur, Putrajaya
- Age
- 18 years and over
- People
- 1,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444EU 2024-513739-25-00Registry updated 2026-10-28
Phase 3RecruitingTrial-stage medicine
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Ampang, Kota Bharu, Kuala Lumpur, Putrajaya
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457EU 2024-513741-36-00Registry updated 2026-10-28
Phase 2Not yet recruitingResearch participation
The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)
- Where
- Cheras
- Age
- 18 years to 65 years
- People
- 26
- Run by
- Universiti Kebangsaan Malaysia Medical Centre
See details and how to joinNCT07466485Registry updated 2026-04-29
All Fatty liver disease (MASLD/MASH) trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.